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Human neurodegenerative disorders are typified by late
onset cell loss in specific brain regions and stereotypic
neuroanatomical and behavioral aberrations. Recent
studies suggest that molecular genetic approaches in
Drosophila may shed important new light on conserved
mechanisms underlying such disorders.
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The most notorious human neurodegenerative disorders,
such as Alzheimer’s disease, Huntington’s disease,
Parkinson’s disease and amyotrophic lateral sclerosis,
typically have a late onset, causing premature death after a
period during which the symptoms inexorably worsen.
Afflicted individuals may exhibit behavioral deficits, such
as ataxia, seizures and tremors, as well as cognitive impair-
ments involving memory loss or dementia. These disor-
ders are associated with moderate to severe cell loss and
anatomical disruptions of specific brain regions. Genes
that might underlie inherited forms of some of the neu-
rodegenerative diseases have been identified, but the
mechanisms by which disruptions in these genes result in
specific disease pathologies are not yet clear [1].
Given the inherent limitations on genetic analysis in
humans, it would clearly be helpful to have relevant
models of human neurodegenerative diseases in geneti-
cally tractable species. Recent studies give strong indica-
tions that the fruit fly Drosophila will be a valuable
experimental subject for studying conserved mecha-
nisms underlying human neurodegenerative disorders
(see [2] for example). We shall discuss these develop-
ments and the complementary experimental approaches
that are being taken to studying neurodegeneration 
in Drosophila. 
Drosophila neurodegeneration mutants and genes
A number of Drosophila mutants have been identified that
exhibit symptoms reminiscent of human neurodegenera-
tive disorders, including some or all of reduced adult
longevity, aberrant behavior and stereotypic brain lesions.
Some examples of these are listed in Table 1. In several
instances, specific phenotypic similarities to human neu-
rodegenerative disorders have been noted. For example,
peripheral nerve hypomyelination or hypermyelination by
Schwann cells is associated with several human neu-
ropathies [3], and similar defects in glial wrapping of
neuron cell bodies and axons are found in the Drosophila
mutants drop dead [4] and swiss cheese [5]. 
Wild-type adult fruit flies generally live for 2–3 months,
but drop dead mutants typically die within their first week
of adulthood. Although newly emerged drop dead flies
appear normal, they soon exhibit decreased motor activity,
and their brain glia have stunted cytoplasmic processes
that fail to enwrap neighboring neurons properly. Adult
drop dead mutants also show accelerated age-dependent
changes in gene expression patterns [6], implying that
aging processes may be disrupted. The drop dead gene
encodes a novel transmembrane protein expressed in
brain tracheole cells (S. Benzer, personal communication),
suggesting that the brain defects in drop dead mutants may
arise at least in part from hypoxia.
In swiss cheese mutant flies, large vacuoles form in the brain
and widespread neuronal and glial cell death is detected.
Glial processes form abnormal, multi-layered wrappings
around neurons and axons in the mutant brains. The swiss
cheese gene is expressed by neurons in the brain cortex and
encodes a membrane protein related to the human protein
known as neuropathy target esterase [7]. Chemical inhibi-
tion of neuropathy target esterase has been shown to
result in a delayed degeneration of long axons in the spinal
cord and peripheral nerves. The Swiss Cheese protein also
contains a region of homology to the cAMP-binding regu-
latory subunit of protein kinase A [5,7], which is thought
to be an important component of intracellular signaling
pathways in vertebrate neurons and glia.
Drosophila spongecake mutants show temperature- and age-
dependent formation of large vacuoles and degeneration
of neuronal axons in the optic lobes [8]. The axon
terminals swell and neighboring axons often coalesce to
form vacuolar structures similar in appearance to those
found in brains of humans with Creutzfeld–Jakob disease.
Mutations in the eggroll gene result in widespread degen-
eration in the optic lobe and central brain, followed by
retinal degeneration [8]. In eggroll mutant brains, neurons
and glia contain multi-laminar structures similar to those
seen in humans with Tay–Sachs disease. These structures
are detected in the brains, not only of adults, but also of
third instar larvae, indicating that cellular defects begin to
accumulate well before symptoms are evident.
A number of human and fly neurodegeneration disorders
result in very specific behavioral aberrations. The
Drosophila pirouette mutant exhibits auditory deficits and
age-dependent circling behaviors that progress in severity
from an abrupt ‘about face’ turning behavior to turning in
increasingly tighter circles [9]. These flies also exhibit
massive, often asymmetric degeneration of brain tissues.
Similar circling behaviors are exhibited by several mouse
neurological mutants, as well as by humans with a disorder
known as hemi-parkinsonism [10].
Gene-specific lesions in Drosophila can thus induce neural
defects with many of the hallmarks of human neurodegen-
erative disorders. One crucial question is whether defects
in homologous genes can cause similar neurodegeneration
in flies and humans. A number of Drosophila homologs
have been identified of human genes that have been
linked to neurodegenerative disease (Table 1). The
Drosophila gene beta-amyloid protein precursor-like (Appl)
[11], for example, encodes a homolog of the human β-
amyloid precursor protein (APP), which gives rise to β-
amyloid, a major component of the plaques in the brains
of Alzheimer’s disease sufferers. In mice, APP mutations
result in reduced locomotor activity as well as glial degen-
eration. In Drosophila the Appl protein is exclusively
expressed in differentiated neurons, and deletions of the
Appl gene result in adult locomotor defects [11]. These
behavioral defects can be partially rescued by ubiquitous
expression of either fly Appl or human APP, indicating
that these homologous genes are functionally conserved.
A Drosophila homolog [12] has also been identified of the
human gene for the Cu2+/Zn2+ superoxide dismutase.
Mutations of this gene have been implicated in Lou
Gehrig’s disease, a familial form of amyotrophic lateral
sclerosis that results in motor neuron degeneration and
paralysis. Deletion mutations of the Drosophila superoxide
dismutase gene cause a reduction in lifespan and hypersen-
sitivity to oxygen stress, while at least one missense muta-
tion of the gene results in degeneration of photoreceptor
neurons and pigment cells throughout the retina.
Glutamine-repeat disease in Drosophila
Many dominantly-inherited human neurodegenerative
diseases, including Huntington’s disease, spinocerebellar
ataxia and myotonic dystrophy, are caused by expansions
of trinucleotide repeats coding for glutamine residues in a
specific gene product [13,14]. Similar neurological pheno-
types can be induced in transgenic mice ‘models’ express-
ing the corresponding proteins with expanded
glutamine-repeat regions. The glutamine-repeat diseases
share several distinctive properties. Firstly, the symptoms
arise only when the repeat number exceeds a characteris-
tic threshold for each gene. Secondly, affected lineages
show genetic ‘anticipation’: repeat lengths increase in suc-
cessive generations, resulting in increasing severity and
earlier onset of symptoms. And thirdly, although most of
these proteins are normally cytoplasmic and widely
expressed, the disease-associated versions aggregate in
nuclear inclusions present only in the affected cells. 
Two important questions concerning neurodegenerative
diseases of this type immediately arise. These are, firstly,
what is the relationship between nuclear inclusion forma-
tion and disease pathogenesis? And secondly, are there
common pathogenic mechanisms that underlie the various
glutamine-repeat diseases? The answers to these ques-
tions are not known, but it has been suggested that the
expanded poly-glutamine tracts might act as ‘polar
zippers’ that can mediate aberrant protein–protein interac-
tions, or as aberrant substrates for cross-linking by transg-
lutaminases. Either property could lead to the mutant
proteins promoting the formation of heterologous insolu-
ble protein aggregates that may ultimately result in the
titration and loss of activity of vital cellular proteins.
In Drosophila, there are a large number of proteins that
contain poly-glutamine tracts and function in nervous
system development [15]. Although there are as yet no
known examples of triplet-repeat expansion in an endoge-
nous Drosophila gene that cause a neurodegenerative phe-
notype, naturally-occurring polymorphisms in sequences
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Table 1
Drosophila neurodegeneration mutants and genes.
Gene or mutation Mutant phenotype Human homolog
drop dead [4] Glial hypo-wrapping None known
swiss cheese [5,7] Brain vacuoles, glial Neuropathy 
hyperventilation target esterase
spongecake [8] Axon degeneration ND
and fusions
eggroll [8] Neuronal and glial ND
degeneration, multi-
laminar structures
Vacuolar medulla [18] Optic lobe ND
degeneration, optomotor
response defects
pirouette [9] Circling behavior, brain ND
degeneration
beta-amyloid protein Locomotor defects β-amyloid 
precursor-like [11] precursor
Superoxide dismutase Retinal degeneration Cu2+/Zn2+
[12] superoxide
dismutase
ripped pocket / pick ND Degenerin sodium
pocket [19] channel subunit
Presenilin [20,21] ND Presenilins
retinal degeneration C Light-induced Serine/threonine
[2] degeneration phosphatase
neither inactivation nor Retinal degeneration Rhodopsin
action potential E [2]
ND, not yet determined.
encoding poly-glutamine tracts have been observed [16].
And it was recently found that a human protein with an
expanded glutamine repeat region can induce neurode-
generation in Drosophila. This was accomplished by tar-
geted expression of a transgene coding for a mutant
protein associated with Machado Joseph’s syndrome [17],
a common form of spinocerebellar ataxia. Expression of a
normal version of the protein, MJDtr-Q27, with 27 gluta-
mine repeats, had no phenotypic effects in any of several
tissues examined. This form of the protein was consis-
tently cytoplasmic, and no nuclear inclusion formation was
seen. In contrast, expression of the mutant form MJDtr-
Q78, with 78 glutamine repeats, led to reduced lifespan,
age-dependent cell loss and nuclear inclusion formation.
These effects showed apparent dosage-sensitivity and
strong tissue specificity, suggesting that, as in humans,
other, cell-specific factors are essential for pathogenesis. 
MJDtr-Q78 had a dynamic subcellular localization in the
transgenic flies that varied with age. During eye imaginal
disc development, for example, the protein moved from
cytoplasm to nucleus in differentiating photoreceptor
neurons. This nuclear localization correlated with
nuclear inclusion formation and subsequent cellular
degeneration. Interestingly, nuclear inclusions were also
detected in epithelial cells of the imaginal discs, where
no degeneration was observed. Thus, at least in
Drosophila, nuclear inclusion formation is not sufficient
to cause degeneration. 
An important goal of such studies will be to decipher the
basis for the tissue-specific effects of expanded glutamine-
repeat proteins. With Drosophila, it should be possible to
identify other genes involved in disease pathogenesis by
carrying out genetic screens for second-site modifiers of
MJDtr-Q78-induced phenotypes. This may permit identi-
fication of genes encoding proteins that specifically inhibit
or support nuclear inclusion formation, and that might
directly or indirectly interact with MJDtr-Q78. This
approach should strongly complement other methods used
to identify tissue-specific factors that directly associate
with expanded poly-glutamine tracts [13,14].
It will be of interest to see whether other human
glutamine-repeat proteins induce distinct neurodegenera-
tion phenotypes when their mutant forms are expressed in
transgenic fruit flies. If so, perhaps Drosophila can be used
to help identify both common and gene-specific mecha-
nisms underlying the various glutamine-repeat diseases.
Other issues of interest are whether the repeats are geneti-
cally unstable and undergo expansion in Drosophila, and
whether this results in ‘anticipation’. There may exist
species-specific aspects of genome organization or DNA
metabolism that affect the accurate maintenance of triplet
repeats, and perhaps distinct thresholds of repeat numbers
required to induce neurodegeneration. At any rate, repeat
expansion is not a requisite for effectively modeling gluta-
mine-repeat disease, and analyzing any mechanistic differ-
ences should also be highly informative.
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